PTCH1 and glioblastoma: In human primary glioblastoma initiating cells, sonidegib reduces levels of GLI1, GLI2, PTCH1, and PTCH2 messenger ribonucleic acid (RNA) and protein, as well as GLI1 and GLI2 translocation into the nucleus [23].